Lactic acid bacteria show promiseThe Role of Lactic Acid Bacteria in Improving Behavioral Deficits, Serum Levels of Vitamin D3, B12 and Reducing Oxidative Stress and Demyelination in a Cuprizone-induced Demyelination Model of Rat.
High relevance for MS research
We explored how Lactobacillus and Bifidobacterium from traditional dairy might help with multiple sclerosis. In a study with 48 male rats, we induced demyelination and then supplemented with various lactic acid bacteria.
The results were promising! The bacteria helped reduce behavioral deficits, oxidative stress, and demyelination. Additionally, we noticed an increase in important vitamins D and B levels.
While more research is needed, these findings suggest a possible new avenue for treating demyelinating disorders like multiple sclerosis.
Read More
Probiotics show limited benefits in MSThe Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Relevant findings on inflammation
We explored the effects of probiotic supplementation on patients with multiple sclerosis through a randomized, double-blind, placebo-controlled trial.
For 12 weeks, 40 participants received either a probiotic blend containing Lactobacillus acidophilus or a placebo.
Results showed that this probiotic significantly reduced specific inflammatory markers, like IL-8 and TNF-α, but had no significant impact on other genes related to inflammation, insulin, or lipids.
Thus, while there are some positive changes, the overall benefits of the probiotic treatment remain limited.
Read More